In vivo studies of monoclonal anti-D and the mechanism of immune suppression

Transfusion Clinique et Biologique

Volumn 9, Issue 1, 2002, Pages 9-14

  Kumpel, Belinda M ^a,b,c  

^a NHS BLOOD AND TRANSPLANT   (United Kingdom)

^b BIO PRODUCTS LABORATORY   (United Kingdom)

^c National Blood Service Centres ^*

Author keywords

Antibody mediated immune suppression; Fc R; Monoclonal anti D; Red cells; Rh D prophylaxis

Indexed keywords

FC RECEPTOR; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G3; LYMPHOCYTE ANTIGEN RECEPTOR; MONOCLONAL ANTIBODY; RHESUS D ANTIBODY;

B LYMPHOCYTE; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CROSS LINKING; ERYTHROCYTE; HALF LIFE TIME; HEMOLYTIC ANEMIA; HUMAN; HUMAN CELL; IMMUNIZATION; IMMUNOREGULATION; MULTICENTER STUDY; NEWBORN HEMOLYTIC DISEASE; PREGNANCY;

EID: 0036177942     PISSN: 12467820     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1246-7820(01)00209-9     Document Type: Conference Paper

References (45)

1. FcR-mediated inhibition of cell activation and other forms of coinhibition
2. Fc receptor off-signal in the B cell involves apoptosis
3. A transforming growth factor ß-like immunosuppressive factor in immunoglobulin G-binding factor
4. New nomenclature for the Reth motif (or ARH1/TAM/ARAM/YXXL)
5. Decline in deaths from Rhesus haemolytic disease of the newborn
6. Treatment of refractory immune thrombocytopenic purpura with an anti-Fcγ-receptor antibody
7. Blockade of clearance of immune complexes by an anti-Fcγ receptor monoclonal antibody
8. Combined study. Prevention of Rh-haemolytic disease: Results of the clinical trial. A combined study from centres in England and Baltimore
9. IgG receptor roles in red cell binding to monocytes and macrophages
10. Clinical significance of IgG Fc receptors and FcγR-directed immunotherapies
11. Prevention of Rh isoimmunization. Progress report of the clinical trial in mothers
12. Plasma half-lives and bioavailability of human monoclonal Rh D antibodies BRAD-3 and BRAD-5 following intramuscular injection into Rh D-negative volunteers
13. Relative functional binding activity of IgG1 and IgG3 anti-D in IgG preparations
14. 0(D) immune response in male volunteers
15. The chemiluminescent response of human monocytes to red cells sensitized with monoclonal anti-Rh(D) antibodies
16. The functional activity of FcγRII and FcγRIII on subsets of human lymphocytes
17. Identification of signaling motifs within human FcγRIIa and FcγRIIb isoforms
18. Removal of incompatible red cells by the spleen
19. Efficient IgG-mediated suppression of primary antibody responses in Fcγ receptor-deficient mice
20. Heterogeneity in the ability of IgG1 monoclonal anti-D to promote lymphocyte-mediated red cell lysis
21. Human monoclonal anti-D antibodies. I. Their production, serology, quantitation and potential use as blood grouping reagents
22. Functional interactions of red cells sensitized by IgG1 and IgG3 hmnan monoclonal anti-D with enzyme-modified human monocytes and FcR-bearing cell lines
23. Galactosylation of human IgG monoclonal anti-D produced by EBV-transformed B-lymphoblastoid cell lines is dependent on culture method and affects Fc receptor-mediated functional activity
24. - volunteers
25. Quantification of IgG anti-D bound to D-positive red cells infused into D-negative subjects after intramuscular injection of monoclonal anti-D
26. Comparison of two FcγRIII-mediated assays of anti-D functional activity, using spleen and K cells
27. Characterization and functional activity of human Rh monoclonal antibodies
28. Antigen topography is critical for interaction of IgG2 anti-red cell antibodies with Fcγ receptors
29. In vitro functional activity of IgG1 and IgG3 polyclonal and monoclonal anti-D
30. 5I chromium-labeled red cells for estimation of red cell clearance or survival in vivo
31. Mechanism of anti-D-mediated immune suppression - A paradox awaiting resolution?
32. Principles of antibody-mediated immune suppression and the prevention of maternal Rh D alloimmunization
33. Monitoring the clearance of fetal RhD-positive red cells in FMH following immunoglobulin administration
34. + Th1/Th2 T cells
35. Quantitation of immunoglobulin classes and subclasses in anti-Rh(D) anti-bodies
36. Mechanisms of Rh immune suppression by Rh immune globulin
37. Appréciation de l'hémorragie foetomaternelle aprés l'accouchement en vue de la prévention de l'immunisation anti-D
38. The use of purified I-labelled anti-γ globulin in the determination of the number of D antigen sites on red cells of different phenotypes
39. A multi-centre trial of monoclonal anti-D in the prevention of Rh-immunisation of RhD- male volunteers by RhD+ red cells
40. Reduced severity of Rh-haemolytic disease after anti-D immunoglobulin
41. The scientific basis of antenatal prophylaxis
42. Human IgG Fc receptor heterogeneity; molecular aspects and clinical implications
43. Prevention of Rh-haemolytic disease: A third report
44. Rh immunisation and its prevention
45. Mechanism of Rh prophylaxis: An experimental study on specificity of suppression